IP Library Granted Patent US 9,795,621
Granted Patent B2
US 9,795,621 · App. 14/654,735 · Granted Oct 24, 2017

Methods and materials for reducing organ transplant rejection or ischemic/reperfusion injury in a subject

Inventors: Chien Ho (Pittsburgh, PA); Li Liu (Pittsburgh, PA); Yijen Wu (Pittsburgh, PA); T. Kevin Hitchens (Pittsburgh, PA); Qing Ye (Pittsburgh, PA)
Assignee: Carnegie Mellon University
A61K31/661A61K9/0019A61K31/047A61K31/20A61K35/35
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,795,621
App. No.
14/654,735
Granted
Oct 24, 2017
Kind
B2
Abstract

Methods and materials for reducing organ transplant rejection or minimizing ischemia or ischemia/reperfusion injury in a subject are described. The methods include administering a fat emulsion before or after the organ transplant or before, at the onset of, or after the ischemic event.

Claims (16)

1. A method of reducing organ transplant rejection due to ischemia or ischemic reperfusion injury in a human subject, the method comprising administering a fat emulsion, wherein the fat emulsion comprises 20% soybean oil, 1.2% Egg yolk phospholipid, and 2.25 glycerin, to the subject before the subject undergoes an organ transplant, wherein the fat emulsion is administered between 24 hours before and 24 hours after the organ transplantation.

2. The method of claim 1 , wherein the fat emulsion is administered between 0.3 and 4 hours before the organ transplantation.

3. The method of claim 1 , wherein the fat emulsion is administered between 0.3 and 3 hours before the organ transplantation.

4. The method of claim 1 wherein the fat emulsion is administered between 0.5 and 1.5 hours before the organ transplantation.

5. The method of claim 1 , wherein the fat emulsion is administered between 4 and 10 hours before the organ transplantation.

6. The method of claim 1 , wherein the fat emulsion is administered between 10 and 24 hours before the organ transplantation.

7. The method of claim 1 , wherein the fat emulsion is administered between 10 and 15 hours before the organ transplantation.

8. The method of claim 1 , wherein said fat emulsion is administered about 1 hour before the organ transplantation.

9. The method of claim 1 , wherein the fat emulsion is administered intravenously to the subject.

10. The method of claim 1 , wherein the organ transplant is a heart transplant.

11. The method of claim 1 , wherein the organ transplant is a kidney transplant.

12. The method of claim 1 , wherein the organ transplant is a liver transplant.

13. The method of claim 1 , wherein the organ transplant is a lung transplant.

14. The method of claim 1 , wherein the organ transplant is a pancreas transplant.

15. The method of claim 1 , wherein the organ transplant rejection is due to ischemia.

16. The method of claim 1 , wherein the organ transplant rejection is due to an ischemic reperfusion injury.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 30, 2024
From: CARNEGIE-MELON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 066381/0935 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2015
From: HO, CHIEN; LIU, LI; WU, YIJEN; HITCHENS, T. KEVIN; YE, QING
To: CARNEGIE MELLON UNIVERSITY
Reel/Frame 036388/0510 →
Continuity (2)
Provisional Application 61848127 · Dec 20, 2012
Related Publication 20150335664A1 · Nov 26, 2015